GLYCOMIMETIC INHIBITORS OF SIGLEC-8
    4.
    发明申请
    GLYCOMIMETIC INHIBITORS OF SIGLEC-8 审中-公开
    SIGCOM-8的GLYCOMIMETIC INHIBITORS

    公开(公告)号:US20090175792A1

    公开(公告)日:2009-07-09

    申请号:US12304879

    申请日:2007-06-19

    IPC分类号: A61K49/00 C12N5/02 A61K31/35

    CPC分类号: A61K31/7036 A61K31/7012

    摘要: Compounds, compositions and methods are provided for detecting or modulating in vitro and in vivo processes mediated by Siglec-8 binding. More specifically, Siglec-8 modulators and their use are described, wherein the Siglec-8 modulators that modulate a Siglec-8-mediated function comprise particular glycomimetics alone or linked to a diagnostic or therapeutic agent.

    摘要翻译: 提供化合物,组合物和方法用于检测或调节由Siglec-8结合介导的体外和体内过程。 更具体地,描述了Siglec-8调节剂及其用途,其中调节Siglec-8介导的功能的Siglec-8调节剂单独包含特定的糖模拟物或与诊断或治疗剂连接。

    Heterobifunctional compounds for selectin inhibition
    5.
    发明申请
    Heterobifunctional compounds for selectin inhibition 审中-公开
    用于选择素抑制的异双功能化合物

    公开(公告)号:US20090036386A1

    公开(公告)日:2009-02-05

    申请号:US11920499

    申请日:2006-05-24

    IPC分类号: A61K31/7042 C07H17/04

    CPC分类号: C07H17/04 C07H19/056

    摘要: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise glycomimetics linked to a compound, for example a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).

    摘要翻译: 提供化合物和方法用于调节由选择素结合介导的体外和体内过程。 更具体地,描述了选择素调节剂及其用途,其中调节(例如,抑制或增强)选择素介导的功能的选择素调节剂包括与化合物连接的糖模拟物,例如称为BASAs的化合物类别(苄基氨基 磺酸)或称为BACAs(苄基氨基羧酸)的一类化合物的成员。

    Disaccharide inflammation inhibitors and uses thereof
    6.
    发明授权
    Disaccharide inflammation inhibitors and uses thereof 失效
    二糖类炎症抑制剂及其用途

    公开(公告)号:US5639734A

    公开(公告)日:1997-06-17

    申请号:US359582

    申请日:1994-12-20

    CPC分类号: C07H15/18 C07H15/203

    摘要: The present invention provides a composition of matter comprising a biosynthetic anti-inflammatory oligosaccharide, comprising the structure of: sugar - sugar - X - R; wherein said sugar is selected from the group consisting of N-acetylneuraminic acid, galactose, N-acetylglucosamine, N-acetylgalactosamine, fucose and mannose; wherein X is a bridging atom selected from the group consisting of oxygen, sulfur, nitrogen and carbon; and wherein R is an aglycone selected from the group consisting of naphthol, naphthalenemethane, indenol, a heterocyclic derivative of indenol, a heterocyclic derivative of naphthol and a heterocyclic derivative of naphthalenemethanol. Also provided is a method of treating an inflammatory disease in an individual comprising the step of administering to said individual a therapeutically effective dose of the novel composition of the present invention.

    摘要翻译: 本发明提供了包含生物合成抗炎寡糖的物质组合物,其包含以下结构:糖 - 糖-X-R; 其中所述糖选自N-乙酰神经氨酸,半乳糖,N-乙酰葡糖胺,N-乙酰半乳糖胺,岩藻糖和甘露糖; 其中X是选自氧,硫,氮和碳的桥连原子; 并且其中R是选自萘酚,萘甲烷,茚醇,茚醇的杂环衍生物,萘酚的杂环衍生物和萘甲醇的杂环衍生物的糖苷配基。 还提供了治疗个体炎性疾病的方法,包括向所述个体施用治疗有效剂量的本发明的新型组合物的步骤。

    Heterobifunctional pan-selectin inhibitors
    7.
    再颁专利
    Heterobifunctional pan-selectin inhibitors 有权
    异双功能泛选择素抑制剂

    公开(公告)号:USRE44778E1

    公开(公告)日:2014-02-25

    申请号:US13484020

    申请日:2012-05-30

    IPC分类号: C07H15/22

    摘要: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise particular glycomimetics alone or linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).

    摘要翻译: 提供化合物和方法用于调节由选择素结合介导的体外和体内过程。 更具体地,描述了选择素调节剂及其用途,其中调节(例如,抑制或增强)选择素介导的功能的选择素调节剂单独包含特定的糖模拟物或连接到称为BASAs的化合物类别(苄基氨基磺酸 )或称为BACAs(苄基氨基羧酸)的一类化合物的成员。

    Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas
    8.
    发明授权
    Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas 有权
    来自假单胞菌的PA-IL凝集素,PA-IIL凝集素或两者的凝集素的模拟抑制剂

    公开(公告)号:US08258290B2

    公开(公告)日:2012-09-04

    申请号:US12370826

    申请日:2009-02-13

    IPC分类号: C07H3/08 C07H3/06 A61K31/702

    摘要: Compositions and methods are provided related to Pseudomonas bacteria. The compositions and methods may be used for diagnosis and therapy of medical conditions involving infection with Pseudomonas bacteria. Such infections include Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. A compound useful in the present methods may be used in combination with a therapeutic agent or may be linked to a therapeutic agent. Pseudomonas bacteria may be inhibited by blocking colonization, inhibiting virulence factors, arresting growth or killing the bacteria.

    摘要翻译: 提供了与假单胞菌属相关的组合物和方法。 组合物和方法可用于诊断和治疗涉及感染假单胞菌的医学病症。 这种感染包括铜绿假单胞菌在囊性纤维化患者的肺部。 可用于本发明方法的化合物可与治疗剂组合使用或可与治疗剂连接。 通过阻断定植,抑制毒力因子,阻止生长或杀死细菌,可以抑制假单胞菌。